Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 7.561
Filtrer
1.
Arh Hig Rada Toksikol ; 75(2): 147-154, 2024 Jun 01.
Article de Anglais | MEDLINE | ID: mdl-38963138

RÉSUMÉ

Mistakes in translation are mostly associated with toxic effects in the cell due to the production of functionally aberrant and misfolded proteins. However, under certain circumstances mistranslation can have beneficial effects and enable cells to preadapt to other stress conditions. Mistranslation may be caused by mistakes made by aminoacyl-tRNA synthetases, essential enzymes that link amino acids to cognate tRNAs. There is an Escherichia coli strain expressing isoleucyl-tRNA synthetase mutant variant with inactivated editing domain which produces mistranslated proteomes where valine (Val) and norvaline (Nva) are misincorporated into proteins instead of isoleucine. We compared this strain with the wild-type to determine the effects of such mistranslation on bacterial growth in oxidative stress conditions. When the cells were pre-incubated with 0.75 mmol/L Nva or 1.5 mmol/L Val or Nva and exposed to hydrogen peroxide, no beneficial effect of mistranslation was observed. However, when the editing-deficient strain was cultivated in medium supplemented with 0.75 mmol/L Val up to the early or mid-exponential phase of growth and then exposed to oxidative stress, it slightly outgrew the wild-type grown in the same conditions. Our results therefore show a modest adaptive effect of isoleucine mistranslation on bacterial growth in oxidative stress, but only in specific conditions. This points to a delicate balance between deleterious and beneficial effects of mistranslation.


Sujet(s)
Escherichia coli , Stress oxydatif , Stress oxydatif/effets des médicaments et des substances chimiques , Escherichia coli/effets des médicaments et des substances chimiques , Escherichia coli/génétique , Biosynthèse des protéines/effets des médicaments et des substances chimiques , Protéines Escherichia coli/génétique , Peroxyde d'hydrogène
2.
Int J Mol Sci ; 25(13)2024 Jul 06.
Article de Anglais | MEDLINE | ID: mdl-39000537

RÉSUMÉ

This research compared how different levels of dietary crude protein (CP) and apparent metabolizable energy (AME) affect the growth performance, nitrogen utilization, serum parameters, protein synthesis, and amino acid (AA) metabolism in broilers aged 1 to 10 days. In a 4 × 3 factorial experimental design, the broilers were fed four levels of dietary CP (20%, 21%, 22%, and 23%) and three levels of dietary AME (2800 kcal/kg, 2900 kcal/kg, and 3000 kcal/kg). A total of 936 one-day-old male Arbor Acres broilers were randomly allocated to 12 treatments with 6 replications each. Growth performance, nitrogen utilization, serum parameter, gene expression of protein synthesis, and AA metabolism were evaluated at 10 d. The results revealed no interaction between dietary CP and AME levels on growth performance (p > 0.05). However, 22% and 23% CP enhanced body weight gain (BWG), the feed conversion ratio (FCR), total CP intake, and body protein deposition but had a detrimental effect on the protein efficiency ratio (PER) compared to 20% or 21% CP (p < 0.05). Broilers fed diets with 2800 kcal/kg AME showed increased feed intake (FI) and inferior PER (p < 0.05). Broilers fed diets with 3000 kcal/kg AME showed decreased muscle mRNA expression of mammalian target of the rapamycin (mTOR) and Atrogin-1 compared to those fed diets with 2800 kcal/kg and 2900 kcal/kg AME (p < 0.05). Increasing dietary CP level from 20% to 23% decreased muscle mTOR and increased S6K1 mRNA expression, respectively (p < 0.05). The muscle mRNA expression of Atrogin-1 was highest for broilers fed 23% CP diets (p < 0.05). The mRNA expression of betaine homocysteine methyltransferase (BHMT) and Liver alanine aminotransferase of the 22% and 23% CP groups were higher than those of 20% CP (p < 0.05). Significant interactions between dietary CP and AME levels were observed for muscle AMPK and liver lysine-ketoglutarate reductase (LKR) and branched-chain alpha-keto acid dehydrogenase (BCKDH) mRNA expression (p < 0.05). Dietary AME level had no effect on muscle AMPK mRNA expression for broilers fed 21% and 22% CP diets (p > 0.05), whereas increasing dietary AME levels decreased AMPK mRNA expression for broilers fed 23% CP diets (p < 0.05). The mRNA expression of LKR and BCKDH was highest for broilers fed the diet with 2800 kcal/kg AME and 22% CP, while it was lowest for broilers fed the diet with 3000 kcal/kg AME and 20% CP. The findings suggest that inadequate energy density hindered AA utilization for protein synthesis, leading to increased AA catabolism for broilers aged 1 to 10 days, and a dietary CP level of 22% and an AME level of 2900 to 3000 kcal/kg may be recommended based on performance and dietary protein utilization.


Sujet(s)
Acides aminés , Aliment pour animaux , Poulets , Protéines alimentaires , Métabolisme énergétique , Azote , Animaux , Poulets/croissance et développement , Poulets/métabolisme , Mâle , Azote/métabolisme , Protéines alimentaires/métabolisme , Protéines alimentaires/administration et posologie , Acides aminés/métabolisme , Aliment pour animaux/analyse , Métabolisme énergétique/effets des médicaments et des substances chimiques , Biosynthèse des protéines/effets des médicaments et des substances chimiques , Phénomènes physiologiques nutritionnels chez l'animal , Régime alimentaire/médecine vétérinaire
3.
Philos Trans R Soc Lond B Biol Sci ; 379(1906): 20230481, 2024 Jul 29.
Article de Anglais | MEDLINE | ID: mdl-38853546

RÉSUMÉ

Group I metabotropic glutamate receptors (Gp1-mGluRs) exert a host of effects on cellular functions, including enhancement of protein synthesis and the associated facilitation of long-term potentiation (LTP) and induction of long-term depression (LTD). However, the complete cascades of events mediating these events are not fully understood. Gp1-mGluRs trigger α-secretase cleavage of amyloid precursor protein, producing soluble amyloid precursor protein-α (sAPPα), a known regulator of LTP. However, the α-cleavage of APP has not previously been linked to Gp1-mGluR's actions. Using rat hippocampal slices, we found that the α-secretase inhibitor tumour necrosis factor-alpha protease inhibitor-1, which inhibits both disintegrin and metalloprotease 10 (ADAM10) and 17 (ADAM17) activity, blocked or reduced the ability of the Gp1-mGluR agonist (R,S)-3,5-dihydroxyphenylglycine (DHPG) to stimulate protein synthesis, metaplastically prime future LTP and elicit sub-maximal LTD. In contrast, the specific ADAM10 antagonist GI254023X did not affect the regulation of plasticity, suggesting that ADAM17 but not ADAM10 is involved in mediating these effects of DHPG. However, neither drug affected LTD that was strongly induced by either high-concentration DHPG or paired-pulse synaptic stimulation. Our data suggest that moderate Gp1-mGluR activation triggers α-secretase sheddase activity targeting APP or other membrane-bound proteins as part of a more complex signalling cascade than previously envisioned. This article is part of a discussion meeting issue 'Long-term potentiation: 50 years on'.


Sujet(s)
Amyloid precursor protein secretases , Hippocampe , Potentialisation à long terme , Dépression synaptique à long terme , Biosynthèse des protéines , Récepteurs métabotropes au glutamate , Animaux , Amyloid precursor protein secretases/métabolisme , Amyloid precursor protein secretases/antagonistes et inhibiteurs , Rats , Récepteurs métabotropes au glutamate/métabolisme , Dépression synaptique à long terme/physiologie , Biosynthèse des protéines/effets des médicaments et des substances chimiques , Hippocampe/métabolisme , Protéine ADAM17/métabolisme , Protéine ADAM10/métabolisme , Rat Sprague-Dawley , Mâle , Méthoxyhydroxyphénylglycol/analogues et dérivés , Méthoxyhydroxyphénylglycol/pharmacologie , Protéines membranaires/métabolisme
4.
Nat Commun ; 15(1): 4783, 2024 Jun 05.
Article de Anglais | MEDLINE | ID: mdl-38839776

RÉSUMÉ

Ribosomes translate the genetic code into proteins. Recent technical advances have facilitated in situ structural analyses of ribosome functional states inside eukaryotic cells and the minimal bacterium Mycoplasma. However, such analyses of Gram-negative bacteria are lacking, despite their ribosomes being major antimicrobial drug targets. Here we compare two E. coli strains, a lab E. coli K-12 and human gut isolate E. coli ED1a, for which tetracycline exhibits bacteriostatic and bactericidal action, respectively. Using our approach for close-to-native E. coli sample preparation, we assess the two strains by cryo-ET and visualize their ribosomes at high resolution in situ. Upon tetracycline treatment, these exhibit virtually identical drug binding sites, yet the conformation distribution of ribosomal complexes differs. While K-12 retains ribosomes in a translation-competent state, tRNAs are lost in the vast majority of ED1a ribosomes. These structural findings together with the proteome-wide abundance and thermal stability assessments indicate that antibiotic responses are complex in cells and can differ between different strains of a single species, thus arguing that all relevant bacterial strains should be analyzed in situ when addressing antibiotic mode of action.


Sujet(s)
Antibactériens , Escherichia coli , Ribosomes , Tétracycline , Ribosomes/métabolisme , Ribosomes/effets des médicaments et des substances chimiques , Antibactériens/pharmacologie , Escherichia coli/effets des médicaments et des substances chimiques , Escherichia coli/génétique , Escherichia coli/métabolisme , Tétracycline/pharmacologie , Cryomicroscopie électronique , ARN de transfert/métabolisme , ARN de transfert/génétique , Humains , Sites de fixation , Biosynthèse des protéines/effets des médicaments et des substances chimiques , Escherichia coli K12/effets des médicaments et des substances chimiques , Escherichia coli K12/génétique , Escherichia coli K12/métabolisme
5.
Cancer Lett ; 595: 217002, 2024 Jul 28.
Article de Anglais | MEDLINE | ID: mdl-38823761

RÉSUMÉ

The mechanism underlying N6-methyladenosine (m6A) modification in bladder cancer (BC) remains elusive. We identified that the RBM15/METTL3 complex enhances m6A modification and promotes the ENO1 protein translation efficiency through its 359A site by depending on YTHDF1 in BC cells. In the tumor microenvironment, TGF-ß effectively stimulates RBM15/METTL3 expression to improve ENO1 mRNA m6A modification through the Smad2/3 pathway. Reduced ENO1 m6A levels hamper tumor proliferation both in vitro and in vivo. Mechanistically, ENO1 augments PCNA protein stability by reducing its K48-linked ubiquitination and thus prevents protein degradation through the endoplasmic reticulum-associated degradation pathway. According to the subsequent experiments, the ENO1 inhibitor significantly reduced tumor proliferation both in vitro and in vivo. Our study highlights the significance of RBM15/METTL3 complex-mediated ENO1 mRNA m6A modification in ENO1 expression. It also reveals a novel mechanism by which ENO1 promotes BC progression, thereby suggesting that ENO1 can be a therapeutic target for BC.


Sujet(s)
Adénosine , Prolifération cellulaire , Protéines de liaison à l'ADN , Évolution de la maladie , Enolase , Protéines de liaison à l'ARN , Protéines suppresseurs de tumeurs , Ubiquitination , Tumeurs de la vessie urinaire , Tumeurs de la vessie urinaire/génétique , Tumeurs de la vessie urinaire/anatomopathologie , Tumeurs de la vessie urinaire/métabolisme , Tumeurs de la vessie urinaire/traitement médicamenteux , Humains , Protéines suppresseurs de tumeurs/génétique , Protéines suppresseurs de tumeurs/métabolisme , Protéines de liaison à l'ADN/génétique , Protéines de liaison à l'ADN/métabolisme , Adénosine/analogues et dérivés , Adénosine/métabolisme , Animaux , Enolase/métabolisme , Enolase/génétique , Lignée cellulaire tumorale , Prolifération cellulaire/effets des médicaments et des substances chimiques , Protéines de liaison à l'ARN/génétique , Protéines de liaison à l'ARN/métabolisme , Souris , Methyltransferases/métabolisme , Methyltransferases/génétique , Régulation de l'expression des gènes tumoraux/effets des médicaments et des substances chimiques , Biosynthèse des protéines/effets des médicaments et des substances chimiques , Souris nude , Marqueurs biologiques tumoraux , Antigène nucléaire de prolifération cellulaire
6.
Int J Biol Macromol ; 273(Pt 1): 132968, 2024 Jul.
Article de Anglais | MEDLINE | ID: mdl-38871097

RÉSUMÉ

Eukaryotic Initiation Translation Factor 2A (EIF2A) is considered to be primarily responsible for the initiation of translation when a cell is subjected to stressful conditions. However, information regarding this protein is still incomplete. Using a combination of proteomic approaches, we demonstrated that EIF2A is the molecular target of the naturally occurring bioactive compound cannabidiolic acid (CBDA) within human glioblastoma cells. This finding allowed us to undertake a study aimed at obtaining further information on the functions that EIF2A plays in tumor cells. Indeed, our data showed that CBDA is able to activate EIF2A when the cells are in no-stress conditions. It induces conformational changes in the protein structure, thus increasing EIF2A affinity towards the proteins participating in the Eukaryotic Translation Machinery. Consequently, following glioblastoma cells incubation with CBDA we observed an enhanced neosynthesis of proteins involved in the stress response, nucleic acid translation and organization, and protein catabolism. These changes in gene expression resulted in increased levels of ubiquitinated proteins and accumulation of the autophagosome. Our results, in addition to shedding light on the molecular mechanism underlying the biological effect of a phytocannabinoid in cancer cells, demonstrated that EIF2A plays a critical role in regulation of protein homeostasis.


Sujet(s)
Facteur-2 d'initiation eucaryote , Glioblastome , Humains , Glioblastome/métabolisme , Glioblastome/anatomopathologie , Facteur-2 d'initiation eucaryote/métabolisme , Lignée cellulaire tumorale , Homéostasie protéique/effets des médicaments et des substances chimiques , Biosynthèse des protéines/effets des médicaments et des substances chimiques , Protéomique/méthodes
7.
Trends Parasitol ; 40(7): 541-543, 2024 Jul.
Article de Anglais | MEDLINE | ID: mdl-38910099

RÉSUMÉ

Small-Saunders et al. uncovered a new facet of artemisinin resistance in Plasmodium in which parasites use a previously underexplored arm of stress response mechanisms. Through altered epitranscriptomic modifications on tRNA, changed translation patterns adapt resistant cells to facilitate entry into a quiescent-like state which provides the parasite an escape from many drugs.


Sujet(s)
Antipaludiques , Artémisinines , Résistance aux substances , Plasmodium falciparum , Plasmodium falciparum/effets des médicaments et des substances chimiques , Plasmodium falciparum/génétique , Artémisinines/pharmacologie , Résistance aux substances/génétique , Antipaludiques/pharmacologie , Humains , Biosynthèse des protéines/effets des médicaments et des substances chimiques , Paludisme à Plasmodium falciparum/parasitologie , Paludisme à Plasmodium falciparum/traitement médicamenteux
8.
Nat Commun ; 15(1): 5481, 2024 Jun 28.
Article de Anglais | MEDLINE | ID: mdl-38942792

RÉSUMÉ

Tigecycline is widely used for treating complicated bacterial infections for which there are no effective drugs. It inhibits bacterial protein translation by blocking the ribosomal A-site. However, even though it is also cytotoxic for human cells, the molecular mechanism of its inhibition remains unclear. Here, we present cryo-EM structures of tigecycline-bound human mitochondrial 55S, 39S, cytoplasmic 80S and yeast cytoplasmic 80S ribosomes. We find that at clinically relevant concentrations, tigecycline effectively targets human 55S mitoribosomes, potentially, by hindering A-site tRNA accommodation and by blocking the peptidyl transfer center. In contrast, tigecycline does not bind to human 80S ribosomes under physiological concentrations. However, at high tigecycline concentrations, in addition to blocking the A-site, both human and yeast 80S ribosomes bind tigecycline at another conserved binding site restricting the movement of the L1 stalk. In conclusion, the observed distinct binding properties of tigecycline may guide new pathways for drug design and therapy.


Sujet(s)
Cryomicroscopie électronique , Ribosomes , Tigecycline , Tigecycline/pharmacologie , Tigecycline/composition chimique , Humains , Ribosomes/métabolisme , Ribosomes/effets des médicaments et des substances chimiques , Antibactériens/pharmacologie , Antibactériens/composition chimique , Sites de fixation , Saccharomyces cerevisiae/effets des médicaments et des substances chimiques , Saccharomyces cerevisiae/métabolisme , Biosynthèse des protéines/effets des médicaments et des substances chimiques , Ribosomes mitochondriaux/métabolisme , Ribosomes mitochondriaux/composition chimique , Ribosomes mitochondriaux/effets des médicaments et des substances chimiques , Modèles moléculaires , ARN de transfert/métabolisme , ARN de transfert/composition chimique
9.
Biomolecules ; 14(5)2024 Apr 28.
Article de Anglais | MEDLINE | ID: mdl-38785934

RÉSUMÉ

Adverse experiences (e.g., acute stress) and alcohol misuse can both impair skeletal muscle homeostasis, resulting in reduced protein synthesis and greater protein breakdown. Exposure to acute stress is a significant risk factor for engaging in alcohol misuse. However, little is known about how these factors together might further affect skeletal muscle health. To that end, this study investigated the effects of acute stress exposure followed by a period of binge-patterned alcohol drinking on signaling factors along mouse skeletal muscle protein synthesis (MPS) and degradation (MPD) pathways. Young adult male C57BL/6J mice participated in the Drinking in the Dark paradigm, where they received 2-4 h of access to 20% ethanol (alcohol group) or water (control group) for four days to establish baseline drinking levels. Three days later, half of the mice in each group were either exposed to a single episode of uncontrollable tail shocks (acute stress) or remained undisturbed in their home cages (no stress). Three days after stress exposure, mice received 4 h of access to 20% ethanol (alcohol) to model binge-patterned alcohol drinking or water for ten consecutive days. Immediately following the final episode of alcohol access, mouse gastrocnemius muscle was extracted to measure changes in relative protein levels along the Akt-mTOR MPS, as well as the ubiquitin-proteasome pathway (UPP) and autophagy MPD pathways via Western blotting. A single exposure to acute stress impaired Akt singling and reduced rates of MPS, independent of alcohol access. This observation was concurrent with a potent increase in heat shock protein seventy expression in the muscle of stressed mice. Alcohol drinking did not exacerbate stress-induced alterations in the MPS and MPD signaling pathways. Instead, changes in the MPS and MPD signaling factors due to alcohol access were primarily observed in non-stressed mice. Taken together, these data suggest that exposure to a stressor of sufficient intensity may cause prolonged disruptions to signaling factors that impact skeletal muscle health and function beyond what could be further induced by periods of alcohol misuse.


Sujet(s)
Hyperalcoolisation rapide , Souris de lignée C57BL , Protéines du muscle , Muscles squelettiques , Protéolyse , Animaux , Mâle , Muscles squelettiques/métabolisme , Muscles squelettiques/effets des médicaments et des substances chimiques , Souris , Protéines du muscle/métabolisme , Protéines du muscle/biosynthèse , Hyperalcoolisation rapide/métabolisme , Protéolyse/effets des médicaments et des substances chimiques , Transduction du signal/effets des médicaments et des substances chimiques , Biosynthèse des protéines/effets des médicaments et des substances chimiques , Éthanol , Stress psychologique/métabolisme , Sérine-thréonine kinases TOR/métabolisme , Consommation d'alcool/métabolisme
10.
Sci Rep ; 14(1): 12295, 2024 05 29.
Article de Anglais | MEDLINE | ID: mdl-38811812

RÉSUMÉ

Intramuscular fat (IMF) in pork holds significant importance for economic performance within the pig industry and dietary calcium supplementation enhances the accumulation of intramuscular fat. Additionally, calcium ions inhibit translation and reduce protein synthesis. However, the mechanism by which calcium regulates IMF deposition in muscle through translation remains largely unknown. In this study, we compared the ribosome profiles of the longissimus dorsi muscles of Duroc × Landrace × Large white pigs from the normal calcium (NC) group or calcium supplement (HC) group by Ribo-seq, and RNA-seq. By integrating multiple-omics analysis, we further discovered 437 genes that were transcriptionally unchanged but translationally altered and these genes were significantly enriched in the oxidative phosphorylation signaling pathway. Furthermore, experimental data showed that inhibiting the expression of COX10 and mtND4L increased triglyceride accumulation in C2C12 cells, providing new targets for intramuscular fat deposition. Finally, this work links dietary calcium, translation regulation and IMF deposition, providing a new strategy for both meat quality and economic performance within the pig industry.


Sujet(s)
Calcium alimentaire , Muscles squelettiques , Animaux , Muscles squelettiques/métabolisme , Muscles squelettiques/effets des médicaments et des substances chimiques , Suidae , Calcium alimentaire/métabolisme , Tissu adipeux/métabolisme , Compléments alimentaires , Souris , Biosynthèse des protéines/effets des médicaments et des substances chimiques , Triglycéride/métabolisme , Calcium/métabolisme
11.
Cell Rep Med ; 5(5): 101552, 2024 May 21.
Article de Anglais | MEDLINE | ID: mdl-38729158

RÉSUMÉ

Y-box binding protein-1 (YB-1) is a proto-oncogenic protein associated with protein translation regulation. It plays a crucial role in the development and progression of triple-negative breast cancer (TNBC). In this study, we describe a promising approach to inhibit YB-1 using SU056, a small-molecule inhibitor. SU056 physically interacts with YB-1 and reduces its expression, which helps to restrain the progression of TNBC. Proteome profiling analysis indicates that the inhibition of YB-1 by SU056 can alter the proteins that regulate protein translation, an essential process for cancer cell growth. Preclinical studies on human cells, mice, and patient-derived xenograft tumor models show the effectiveness of SU056. Moreover, toxicological studies have shown that SU056 treatment and dosing are well tolerated without any adverse effects. Overall, our study provides a strong foundation for the further development of SU056 as a potential treatment option for patients with TNBC by targeting YB-1.


Sujet(s)
Biosynthèse des protéines , Tumeurs du sein triple-négatives , Tests d'activité antitumorale sur modèle de xénogreffe , Protéine-1 de liaison à la boîte Y , Tumeurs du sein triple-négatives/traitement médicamenteux , Tumeurs du sein triple-négatives/métabolisme , Tumeurs du sein triple-négatives/anatomopathologie , Humains , Animaux , Protéine-1 de liaison à la boîte Y/métabolisme , Protéine-1 de liaison à la boîte Y/génétique , Femelle , Lignée cellulaire tumorale , Souris , Biosynthèse des protéines/effets des médicaments et des substances chimiques , Prolifération cellulaire/effets des médicaments et des substances chimiques , Régulation de l'expression des gènes tumoraux/effets des médicaments et des substances chimiques , Souris nude
12.
ACS Infect Dis ; 10(6): 2183-2195, 2024 Jun 14.
Article de Anglais | MEDLINE | ID: mdl-38695481

RÉSUMÉ

Chemicals bacteria encounter at the infection site could shape their stress and antibiotic responses; such effects are typically undetected under standard lab conditions. Polyamines are small molecules typically overproduced by the host during infection and have been shown to alter bacterial stress responses. We sought to determine the effect of polyamines on the antibiotic response of Klebsiella pneumoniae, a Gram-negative priority pathogen. Interestingly, putrescine and other natural polyamines sensitized K. pneumoniae to azithromycin, a macrolide protein translation inhibitor typically used for Gram-positive bacteria. This synergy was further potentiated in the physiological buffer, bicarbonate. Chemical genomic screens suggested a dual mechanism, whereby putrescine acts at the membrane and ribosome levels. Putrescine permeabilized the outer membrane of K. pneumoniae (NPN and ß-lactamase assays) and the inner membrane (Escherichia coli ß-galactosidase assays). Chemically and genetically perturbing membranes led to a loss of putrescine-azithromycin synergy. Putrescine also inhibited protein synthesis in an E. coli-derived cell-free protein expression assay simultaneously monitoring transcription and translation. Profiling the putrescine-azithromycin synergy against a combinatorial array of antibiotics targeting various ribosomal sites suggested that putrescine acts as tetracyclines targeting the 30S ribosomal acceptor site. Next, exploiting the natural polyamine-azithromycin synergy, we screened a polyamine analogue library for azithromycin adjuvants, discovering four azithromycin synergists with activity starting from the low micromolar range and mechanisms similar to putrescine. This work sheds light on the bacterial antibiotic responses under conditions more reflective of those at the infection site and provides a new strategy to extend the macrolide spectrum to drug-resistant K. pneumoniae.


Sujet(s)
Antibactériens , Azithromycine , Synergie des médicaments , Klebsiella pneumoniae , Macrolides , Tests de sensibilité microbienne , Polyamines , Klebsiella pneumoniae/effets des médicaments et des substances chimiques , Klebsiella pneumoniae/génétique , Antibactériens/pharmacologie , Azithromycine/pharmacologie , Polyamines/pharmacologie , Polyamines/métabolisme , Macrolides/pharmacologie , Putrescine/pharmacologie , Escherichia coli/effets des médicaments et des substances chimiques , Escherichia coli/génétique , Biosynthèse des protéines/effets des médicaments et des substances chimiques
13.
Anim Biotechnol ; 35(1): 2351973, 2024 May 08.
Article de Anglais | MEDLINE | ID: mdl-38753962

RÉSUMÉ

Vitamin A is an essential nutrient in animals, playing important roles in animal health. In the pig industry, proper supplementation of vitamin A in the feed can improve pork production performance, while deficiency or excessive intake can lead to growth retardation or disease. However, the specific molecular mechanisms through which vitamin A operates on pig skeletal muscle growth as well as muscle stem cell function remain unexplored. Therefore, in this study, we isolated the pig primary skeletal muscle stem cells (pMuSCs) and treated with retinoic acid (RA), the natural metabolite of vitamin A, and then examined the myogenic capacity of pMuSCs via immunostaining, real-time PCR, CCK8 and western-blot analysis. Unexpectedly, the RA caused a significant decrease in the proliferation and differentiation of pMuSCs. Mechanistically, the RA addition induced the activation of retinoic acid receptor gamma (RARγ), which inhibited the myogenesis through the blockage of protein translation of the master myogenic regulator myogenic differentiation 1 gene (MYOD). Specifically, RARγ inactivate AKT kinase (AKT) signalling and lead to dephosphorylation of eukaryotic translation initiation factor 4E binding protein 1 (eIF4EBP1), which in turn repress the eukaryotic translation initiation factor 4E (eIF4E) complex and block mRNA translation of MYOD. Inhibition of AKT could rescue the myogenic defects of RA-treated pMuSCs. Our findings revealed that retinoid acid signalling inhibits the skeletal muscle stem cell proliferation and differentiation in pigs. Therefore, the vitamin A supplement in the feedstuff should be cautiously optimized to avoid the potential adverse consequences on muscle development associated with the excessive levels of retinoic acid.


Sujet(s)
Différenciation cellulaire , Développement musculaire , Protéine MyoD , Transduction du signal , Trétinoïne , Animaux , Trétinoïne/pharmacologie , Suidae , Développement musculaire/effets des médicaments et des substances chimiques , Transduction du signal/effets des médicaments et des substances chimiques , Protéine MyoD/génétique , Protéine MyoD/métabolisme , Différenciation cellulaire/effets des médicaments et des substances chimiques , Muscles squelettiques/effets des médicaments et des substances chimiques , Récepteurs à l'acide rétinoïque/métabolisme , Récepteurs à l'acide rétinoïque/génétique , Prolifération cellulaire/effets des médicaments et des substances chimiques , Biosynthèse des protéines/effets des médicaments et des substances chimiques , Cellules cultivées
14.
Phytomedicine ; 130: 155747, 2024 Jul 25.
Article de Anglais | MEDLINE | ID: mdl-38788397

RÉSUMÉ

BACKGROUND: Chronic inflammation, which becomes more prevalent during aging, contributes to sarcopenia by reducing muscle mass and strength. PURPOSE: Wheat seedlings extract (WSE) is known for its various physiological activities, including anti-inflammation and antioxidant effects. However, its efficacy against sarcopenia is not well documented. STUDY DESIGN: 8-week-old and 50-week-old C57BL/6 J mice were used as young control (YC group) and aged controls (AC group), respectively. Then, aged mice were randomly divided into 5 groups (WSE100mg/kg, WSE200mg/kg, WSE400mg/kg, and schizandrin as a positive control) and fed each experimental diet for 10 weeks. METHOD: We investigated the effects of WSE on muscle quality and protein homeostasis pathways based on improvements in mitochondrial function and chronic inflammation. We then used TNFα-treated C2C12 to investigate the effects of isoorientin (ISO) and isoschaftoside (ISS), the active substances of WSE, on the myogenic pathway. RESULTS: We administered WSE to aging mice and observed an increase in muscle mass, thickness, protein content, and strength in mice treated with WSE at a dose of 200 mg/kg or 400 mg/kg. Furthermore, the administration of WSE led to a reduction in inflammatory factors (TNFα, IL-1, and IL-6) and an increase in mitochondrial biogenesis (p-AMPK/SIRT3/PGC1α) in muscle. This effect was also observed in TNFα-induced muscle atrophy in C2C12 cells, and we additionally identified the upregulation of myogenic regulatory factors, including Myf5, Myf6, MyoD, and myogenin, by WSE, ISO, and ISS. CONCLUSION: These findings suggest that WSE could function as a dietary anti-inflammatory factor and mitochondrial activator, potentially exerting modulatory effects on the metabolism and mechanical properties of skeletal muscles in the aging population. Furthermore, Our results demonstrate the potential value of ISO and ISS as functional food ingredients for preventing muscle atrophy.


Sujet(s)
Anti-inflammatoires , Souris de lignée C57BL , Biogenèse des organelles , Extraits de plantes , Sarcopénie , Plant , Triticum , Animaux , Sarcopénie/traitement médicamenteux , Extraits de plantes/pharmacologie , Anti-inflammatoires/pharmacologie , Mâle , Triticum/composition chimique , Muscles squelettiques/effets des médicaments et des substances chimiques , Muscles squelettiques/métabolisme , Vieillissement/effets des médicaments et des substances chimiques , Souris , Biosynthèse des protéines/effets des médicaments et des substances chimiques , Protéolyse/effets des médicaments et des substances chimiques , Facteur de nécrose tumorale alpha/métabolisme , Mitochondries/effets des médicaments et des substances chimiques , Mitochondries/métabolisme , Coactivateur 1-alpha du récepteur gamma activé par les proliférateurs de peroxysomes/métabolisme , Lignanes/pharmacologie
15.
J Microbiol Biotechnol ; 34(6): 1348-1355, 2024 Jun 28.
Article de Anglais | MEDLINE | ID: mdl-38755008

RÉSUMÉ

The eukaryotic translation initiation factor eIF5B is a bacterial IF2 ortholog that plays an important role in ribosome joining and stabilization of the initiator tRNA on the AUG start codon during the initiation of translation. We identified the fluorophenyl oxazole derivative 2,2-dibromo-1-(2-(4-fluorophenyl)benzo[d]oxazol-5-yl)ethanone quinolinol as an inhibitor of fungal protein synthesis using an in vitro translation assay in a fungal system. Mutants resistant to this compound were isolated in Saccharomyces cerevisiae and were demonstrated to contain amino acid substitutions in eIF5B that conferred the resistance. These results suggest that eIF5B is a target of potential antifungal compound and that mutation of eIF5B can confer resistance. Subsequent identification of 16 other mutants revealed that primary mutations clustered mainly on domain 2 of eIF5B and secondarily mainly on domain 4. Domain 2 has been implicated in the interaction with the small ribosomal subunit during initiation of translation. The tested translation inhibitor could act by weakening the functional contact between eIF5B and the ribosome complex. This data provides the basis for the development of a new family of antifungals.


Sujet(s)
Antifongiques , Facteurs d'initiation eucaryotes , Saccharomyces cerevisiae , Saccharomyces cerevisiae/génétique , Saccharomyces cerevisiae/métabolisme , Saccharomyces cerevisiae/effets des médicaments et des substances chimiques , Facteurs d'initiation eucaryotes/métabolisme , Facteurs d'initiation eucaryotes/génétique , Antifongiques/pharmacologie , Mutation , Biosynthèse des protéines/effets des médicaments et des substances chimiques , Résistance des champignons aux médicaments/génétique , Protéines de Saccharomyces cerevisiae/génétique , Protéines de Saccharomyces cerevisiae/métabolisme , Protéines de Saccharomyces cerevisiae/antagonistes et inhibiteurs , Inhibiteurs de la synthèse protéique/pharmacologie , Substitution d'acide aminé
16.
J Biol Chem ; 300(6): 107360, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38735477

RÉSUMÉ

The nascent polypeptide chains passing through the ribosome tunnel not only serve as an intermediate of protein synthesis but also, in some cases, act as dynamic genetic information, controlling translation through interaction with the ribosome. One notable example is Escherichia coli SecM, in which translation of the ribosome arresting peptide (RAP) sequence in SecM leads to robust elongation arrest. Translation regulations, including the SecM-induced translation arrest, play regulatory roles such as gene expression control. Recent investigations have indicated that the insertion of a peptide sequence, SKIK (or MSKIK), into the adjacent N-terminus of the RAP sequence of SecM behaves as an "arrest canceler". As the study did not provide a direct assessment of the strength of translation arrest, we conducted detailed biochemical analyses. The results revealed that the effect of SKIK insertion on weakening SecM-induced translation arrest was not specific to the SKIK sequence, that is, other tetrapeptide sequences inserted just before the RAP sequence also attenuated the arrest. Our data suggest that SKIK or other tetrapeptide insertions disrupt the context of the RAP sequence rather than canceling or preventing the translation arrest.


Sujet(s)
Protéines Escherichia coli , Escherichia coli , Biosynthèse des protéines , Ribosomes , Ribosomes/métabolisme , Escherichia coli/métabolisme , Escherichia coli/génétique , Protéines Escherichia coli/métabolisme , Protéines Escherichia coli/génétique , Protéines Escherichia coli/composition chimique , Biosynthèse des protéines/effets des médicaments et des substances chimiques , Peptides/composition chimique , Peptides/métabolisme , Peptides/pharmacologie , Séquence d'acides aminés , Oligopeptides/composition chimique , Oligopeptides/pharmacologie , Oligopeptides/métabolisme , Facteurs de transcription
17.
Hippocampus ; 34(8): 380-392, 2024 Aug.
Article de Anglais | MEDLINE | ID: mdl-38785391

RÉSUMÉ

The consolidation of memory is thought to ultimately depend on the synthesis of new proteins, since translational inhibitors such as anisomycin and cycloheximide adversely affect the permanence of long-term memory. However, when applied directly in brain, these agents also profoundly suppress neural activity to an extent that is directly correlated to the degree of protein synthesis inhibition caused. Given that neural activity itself is likely to help mediate consolidation, this finding is a serious criticism of the strict de novo protein hypothesis of memory. Here, we test the neurophysiological effects of another translational inhibitor, emetine. Unilateral intra-hippocampal infusion of emetine suppressed ongoing local field and multiunit activity at ipsilateral sites as compared to the contralateral hippocampus in a fashion that was positively correlated to the degree of protein synthesis inhibition as confirmed by autoradiography. This suppression of activity was also specific to the circumscribed brain region in which protein synthesis inhibition took place. These experiments provide further evidence that ongoing protein synthesis is necessary and fundamental for neural function and suggest that the disruption of memory observed in behavioral experiments using translational inhibitors may be due, in large part, to neural suppression.


Sujet(s)
Émétine , Hippocampe , Inhibiteurs de la synthèse protéique , Émétine/pharmacologie , Animaux , Inhibiteurs de la synthèse protéique/pharmacologie , Hippocampe/effets des médicaments et des substances chimiques , Hippocampe/métabolisme , Hippocampe/physiologie , Mâle , Biosynthèse des protéines/effets des médicaments et des substances chimiques , Biosynthèse des protéines/physiologie , Rats , Neurones/effets des médicaments et des substances chimiques , Potentiels d'action/effets des médicaments et des substances chimiques , Potentiels d'action/physiologie , Rat Sprague-Dawley
18.
Food Funct ; 15(8): 4564-4574, 2024 Apr 22.
Article de Anglais | MEDLINE | ID: mdl-38584588

RÉSUMÉ

This study aimed to investigate the potential of beef peptides (BPs) in mitigating muscle atrophy induced by dexamethasone (DEX) with underlying three mechanisms in vitro (protein degradation, protein synthesis, and the oxidative stress pathway). Finally, the anti-atrophic effect of BPs was enhanced through purification and isolation. BPs were generated using beef loin hydrolyzed with alcalase/ProteAX/trypsin, each at a concentration of 0.67%, followed by ultrafiltration through a 3 kDa cut-off. BPs (10-100 µg mL-1) dose-dependently counteracted the DEX-induced reductions in myotube diameters, differentiation, fusion, and maturation indices (p < 0.05). Additionally, BPs significantly reduced FoxO1 protein dephosphorylation, thereby suppressing muscle-specific E3 ubiquitin ligases such as muscle RING-finger containing protein-1 and muscle atrophy F-box protein in C2C12 myotubes at concentrations exceeding 25 µg mL-1 (p < 0.05). BPs also enhanced the phosphorylation of protein synthesis markers, including mTOR, 4E-BP1, and p70S6K1, in a dose-dependent manner (p < 0.05) and increased the mRNA expression of antioxidant enzymes. Fractionated peptides derived from BPs, through size exclusion and polarity-based fractionation, also demonstrated enhanced anti-atrophic effects compared to BPs. These peptides downregulated the mRNA expression of primary muscle atrophy markers while upregulated that of antioxidant enzymes. Specifically, peptides GAGAAGAPAGGA (MW 924.5) and AFRSSTKK (MW 826.4) were identified from fractionated peptides of BPs. These findings suggest that BPs, specifically the peptide fractions GAGAAGAPAGGA and AFRSSTKK, could be a potential strategy to mitigate glucocorticoid-induced skeletal muscle atrophy by reducing the E3 ubiquitin ligase activity.


Sujet(s)
Fibres musculaires squelettiques , Amyotrophie , Stress oxydatif , Peptides , Animaux , Amyotrophie/traitement médicamenteux , Amyotrophie/métabolisme , Fibres musculaires squelettiques/effets des médicaments et des substances chimiques , Fibres musculaires squelettiques/métabolisme , Souris , Stress oxydatif/effets des médicaments et des substances chimiques , Peptides/pharmacologie , Bovins , Protéolyse/effets des médicaments et des substances chimiques , Lignée cellulaire , Biosynthèse des protéines/effets des médicaments et des substances chimiques , Viande rouge , Protéines du muscle/métabolisme , Dexaméthasone/pharmacologie , Muscles squelettiques/effets des médicaments et des substances chimiques , Muscles squelettiques/métabolisme , Phosphorylation , Sérine-thréonine kinases TOR/métabolisme
19.
Eur J Med Chem ; 271: 116406, 2024 May 05.
Article de Anglais | MEDLINE | ID: mdl-38688064

RÉSUMÉ

NRAS mutation is the second most common oncogenic factor in cutaneous melanoma. Inhibiting NRAS translation by stabilizing the G-quadruplex (G4) structure with small molecules seems to be a potential strategy for cancer therapy due to the NRAS protein's lack of a druggable pocket. To enhance the effects of previously reported G4 stabilizers quindoline derivatives, we designed and synthesized a novel series of quindoline derivatives with fork-shaped side chains by introducing (alkylamino)alkoxy side chains. Panels of experimental results showed that introducing a fork-shaped (alkylamino)alkoxy side chain could enhance the stabilizing abilities of the ligands against NRAS RNA G-quadruplexes and their anti-melanoma activities. One of them, 10b, exhibited good antitumor activity in the NRAS-mutant melanoma xenograft mouse model, showing the therapeutic potential of this kind of compounds.


Sujet(s)
Antinéoplasiques , Conception de médicament , G-quadruplexes , dGTPases , Protéines membranaires , G-quadruplexes/effets des médicaments et des substances chimiques , Humains , Animaux , dGTPases/métabolisme , Souris , Antinéoplasiques/pharmacologie , Antinéoplasiques/synthèse chimique , Antinéoplasiques/composition chimique , Protéines membranaires/antagonistes et inhibiteurs , Protéines membranaires/métabolisme , Protéines membranaires/génétique , Relation structure-activité , Structure moléculaire , Mélanome/traitement médicamenteux , Mélanome/anatomopathologie , Relation dose-effet des médicaments , Prolifération cellulaire/effets des médicaments et des substances chimiques , Indoles/pharmacologie , Indoles/composition chimique , Indoles/synthèse chimique , Lignée cellulaire tumorale , Tests de criblage d'agents antitumoraux , ARN/métabolisme , ARN/composition chimique , Biosynthèse des protéines/effets des médicaments et des substances chimiques , Alcaloïdes , Quinoléines
20.
Neurochem Int ; 176: 105740, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38636905

RÉSUMÉ

The benefits of physical exercise (PE) on memory consolidation have been well-documented in both healthy and memory-impaired animals. However, the underlying mechanisms through which PE exerts these effects are still unclear. In this study, we aimed to investigate the role of hippocampal protein synthesis in memory modulation by acute PE in rats. After novel object recognition (NOR) training, rats were subjected to a 30-min moderate-intensity acute PE on the treadmill, while control animals did not undergo any procedures. Using anisomycin (ANI) and rapamycin (RAPA), compounds that inhibit protein synthesis through different mechanisms, we manipulated protein synthesis in the CA1 region of the hippocampus to examine its contribution to memory consolidation. Memory was assessed on days 1, 7, and 14 post-training. Our results showed that inhibiting protein synthesis by ANI or RAPA impaired NOR memory consolidation in control animals. However, acute PE prevented this impairment without affecting memory persistence. We also evaluated brain-derived neurotrophic factor (BDNF) levels after acute PE at 0.5h, 2h, and 12h afterward and found no differences in levels compared to animals that did not engage in acute PE or were only habituated to the treadmill. Therefore, our findings suggest that acute PE could serve as a non-pharmacological intervention to enhance memory consolidation and prevent memory loss in conditions associated with hippocampal protein synthesis inhibition. This mechanism appears not to depend on BDNF synthesis in the early hours after exercise.


Sujet(s)
Amnésie , Anisomycine , Facteur neurotrophique dérivé du cerveau , Hippocampe , Conditionnement physique d'animal , Rat Wistar , Animaux , Mâle , Conditionnement physique d'animal/physiologie , Rats , Hippocampe/métabolisme , Hippocampe/effets des médicaments et des substances chimiques , Anisomycine/pharmacologie , Facteur neurotrophique dérivé du cerveau/métabolisme , Facteur neurotrophique dérivé du cerveau/biosynthèse , Amnésie/métabolisme , Amnésie/prévention et contrôle , Inhibiteurs de la synthèse protéique/pharmacologie , Sirolimus/pharmacologie , Biosynthèse des protéines/effets des médicaments et des substances chimiques , Biosynthèse des protéines/physiologie , Consolidation de la mémoire/effets des médicaments et des substances chimiques , Consolidation de la mémoire/physiologie , /effets des médicaments et des substances chimiques , /physiologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...